COVID booster uptake is at an all-time low. This shot campaign could save thousands of lives and billions of dollars

aaa
Credit: Getty Images

Boosters are a necessary part of COVID-19 mitigation because vaccine-induced and natural protection against disease have been shown to be transient. However, booster uptake in the United States has steadily declined since the initial wave of the Omicron variant, and federal financial support for vaccination campaigns has not been replenished, partly because of the perception that the pandemic is over. As of October 3, 68 percent of the total U.S. population has been vaccinated with a primary series, but fewer than half of fully vaccinated individuals have received a booster dose. Only 36 percent of people age 50 and older have received their second booster dose.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

We examined three scenarios: a baseline scenario where daily vaccination rates remain unchanged and two vaccine campaign scenarios in which rates increased by the end of 2022.

The two vaccine campaign scenarios where rates increase differ in the level of coverage achieved:

  • In the first scenario, we estimated COVID booster uptake for the eligible population based on age-specific influenza vaccination coverage in 2020–2021 by the end of 2022
  • In the second, we assume 80 percent of eligible individuals age 5 and older receive their booster dose by the end of 2022.

screenshot pm

screenshot pm

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.